Sayfa 319KAYNAKÇA
Barazza, S.: Pay-for-Delay Agreements in the Pharmaceutical Sector: Towards a Coherent EU Approach? European Journal of Risk Regulation 2014, Vol. 5, No. 1, s. 79-86.
Bergqvist, C.: When Do Agreements Restrict Competition in EU Competition Law?, Nordic Journal of European Law 2022, Vol. 1, s. 96-118.
Bové, L.: A Bitter Pill to Swallow: The Legality of Reverse Payment Patent Settlements, Jura Falconis 2016-2017, Vol. 53, No. 4, s. 682-753.
Carrier, M.: A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product Hopping, Fla.L.Rev. 2010, Vol. 62, s. 1009-1036.
Choi, W./Den Uyl, B./Hughes, M.: Pay-For-Delay Practices in the Pharmaceutical Sector: Lundbeck, Actavis, and Others, Journal of European Competition Law & Practice 2014, Vol. 5, No. 1, s. 44-52.
Colangelo, M.: Reverse Payment Patent Settlements in the Pharmaceutical Sector Under EU and US Competition Laws: A Comparative Analysis, World Competition 2017, Vol. 40, No. 3, s. 471-503.
Colomo, P.I.: The legal status of pay-for-delay agreements in EU competition law: Generics (Paroxetine), Common Market Law Review 2020, Vol. 57, s. 1933–1952. (Anılış: Colomo (2020b)).
Colomo, P.I.: Pay-For-Delay and the Structure of Article 101(1) TFEU: Points of Law Raised in Lundbeck and Paroxetine, Journal of European Competition Law & Practice 2020, Vol. 10, No. 10, s. 591-608. (Anılış: Colomo (2020a))
Connor, J.M.: Antitrust Developments in Food and Pharma, Annual Review of Resource Economics 2015, Vol. 7, s. 375-398.
Gallasch, S.: Activating Actavis in Europe – The Proposal of a ‘Structured Effects-Based’ Analysis for Pay-for-Delay Settlements, Legal Studies 2016, Vol. 36 No. 4, s. 683–705.
Gschwindt, D.: Temporary Relief of Pay-for-Delay: The ECJ as Specifically Different Antidepressant, GRUR International 2021, Vol. 70, No. 3, s. 250–256.
Gürkaynak G./Güner, A./Filson, J.: The Global Reach of FTC v. Actavis: Will Europe Differ from the US Approach to Pay- For-Delay Agreements?, International Review of Intellectual Property and Competition Law 2014, Vol. 45, s. 128-160.
Sayfa 320
Gürkaynak, G.: Rekabet Hukukunun İlaç Pazarlarındaki ‘Gecikme için Öde (Pay for Delay)’ Aranjmanlarına Uygulanması: FTC v. Actavis Sonrasında Nereye?, İstanbul Bilgi Üniversitesi Hukuk Fakültesi Rekabet Hukuku Seminerleri, İstanbul 2014.
Hemphill, C.S.: Paying For Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem, New York University Law Review 2006, Vol. 81, s: 1553-1623.
Hemphill, C.S./Lemley, M.A.: Earning Exclusivity: Generic Drug Incentives and the Hatch-Waxman Act, Antitrust L. J., 2011, Vol. 77, s. 947-989.
Henry, D./van Weert, W.: Generics (UK) Ltd and Others v. CMA: Patent Settlement Agreements Unpacked, Journal of European Competition Law & Practice 2020, Vol. 11, No. 7, s. 360-362.
Jawahar, N./Datchayani, B.: Comparison of Generic Drug Application and their Approval Process in US, Europe and Japan, JPSR 2018, Vol. 10, No. 3, s. 523-527.
Kruis, T.: AEUV Art. 101 in: Streinz EUV/AEUV Kommentar, München 2018, para. 274-279.
Langguth, J.: Pay-for-Delay-Vereinbarungen im transatlantischen Vergleich, Baden-Baden 2018.
Lawrance, S./Bond, E.: ‘Reverse-Payment’ Patent Settlement Agreements: Non-Cash Value Transfers are not Immune From Competition Law Scrutiny, Journal of Intellectual Property Law & Practice 2018, Vol. 13, No. 7, s. 552-554.
Lübbig T.: § 8 Rechtsgrundlagen in: Wiedemann Kartellrecht, München 2020.
Shapiro, C.: Antitrust Limits to Patent Settlements, RAND J. Econ. 2003, Vol. 34, No. 2, s. 391-411.
Ska, N./Werner, P./Paul, C.: Pay-for-delay Agreements: Why the EU Should Judge them by their Effects, Journal of European Competition Law & Practice, 2017, Vol. 8, No. 7, s. 437-450.
Treacy, P./Lawrance, S.: Intellectual Property Rights and Out of Court Settlements in: Intellectual Property and Competition Law: New Frontiers, Oxford 2011, s. 277-303.
Treacy, P./Lawrance, S./Henry, O.:‘Pay-for-delay’ Agreements: Guidance from the Court of Justice of the European Union in Case C-307/18 Generics (UK) Limited & Others v Competition and Markets Authority, Journal of Intellectual Property Law & Practice 2020, Vol. 15, No. 6, s. 460-469.
Sayfa 321
Weiswasser, E.S./Danzis, S.D.: The Hatch– Waxman Act: History, Structure, and Legacy, Antitrust L. J. 2003, Vol. 71, s. 585-608.
Welge, J.: Die kartellrechtliche Zulässigkeit von Pay-for-Delay-Vereinbarungen in den USA und der EU, Berlin 2017.
Whish, R./Bailey, D.: Competition Law, Oxford 2021.
Wright, J./Ginsburg, D.H.: The Goals of Antitrust: Welfare Trumps Choice, Fordham L.R. 2013, Vol. 81, s. 2405-2423.
EN
TR
